EXAS

Exact Sciences Corp

Oct 16 • 04:00PM ET

61.29

+0.71 1.17 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB VBK XBI VXF ARKK IWR FBT VHT SCHM

Index	-	P/E	-	EPS (ttm)	-5.42	Insider Own	1.37%	Shs Outstand	189.22M	Perf Week	3.08%
Market Cap	11.60B	Forward P/E	122.34	EPS next Y	0.50	Insider Trans	-0.31%	Shs Float	186.73M	Perf Month	17.01%
Enterprise Value	13.28B	PEG	-	EPS next Q	-0.04	Inst Own	95.12%	Short Float	3.60%	Perf Quarter	21.46%
Income	-1.01B	P/S	3.95	EPS this Y	91.35%	Inst Trans	-5.76%	Short Ratio	2.32	Perf Half Y	45.03%
Sales	2.94B	P/B	4.70	EPS next Y	203.63%	ROA	-16.12%	Short Interest	6.72M	Perf YTD	9.08%
Book/sh	13.05	P/C	13.52	EPS next 5Y	-	ROE	-35.51%	52W High	72.83 -15.85%	Perf Year	-13.54%
Cash/sh	4.53	P/FCF	68.41	EPS past 3/5Y	-17.13% -54.24%	ROIC	-20.23%	52W Low	38.81 57.92%	Perf 3Y	90.58%
Dividend Est.	-	EV/EBITDA	259.97	Sales past 3/5Y	16.01% 25.78%	Gross Margin	69.52%	Volatility	3.25% 2.78%	Perf 5Y	-43.22%
Dividend TTM	-	EV/Sales	4.52	EPS Y/Y TTM	-464.28%	Oper. Margin	-5.65%	ATR (14)	1.67	Perf 10Y	685.77%
Dividend Ex-Date	-	Quick Ratio	2.56	Sales Y/Y TTM	12.56%	Profit Margin	-34.19%	RSI (14)	75.26	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	2.89	EPS Q/Q	92.66%	SMA20	8.35%	Beta	1.32	Target Price	68.20
Payout	-	Debt/Eq	1.03	Sales Q/Q	15.99%	SMA50	18.44%	Rel Volume	0.65	Prev Close	60.58
Employees	7000	LT Debt/Eq	1.01	Earnings	Nov 03 AMC	SMA200	20.15%	Avg Volume	2.89M	Price	61.29
IPO	Jan 31, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	92.08% 4.82%	Trades		Volume	1,875,659	Change	1.17%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$60
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$52
Jan-23-25	Initiated	Barclays	Overweight	$70
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50

Show Previous Ratings

Today 08:49AM	TMO to Report Q3 Earnings: Life Science Solutions Segment in Focus (Zacks)
08:46AM	Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings? (Zacks)
Oct-15-25 09:17AM	Teladoc Health Expands Clarity Platform With Workplace Safety Tool (Zacks)
08:40AM	Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock? (Zacks)
Oct-14-25 08:38AM	Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings (Zacks)
08:44AM	Loading…
Oct-10-25 08:44AM	Abbott to Report Q3 Earnings: Medical Devices Arm in Focus (Zacks)
08:02AM	5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3 (Zacks)
Oct-09-25 10:57AM	BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers (Zacks)
09:50AM	Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock (Zacks)
Oct-08-25 11:16AM	TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus (Zacks)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:00AM	Exact Sciences Schedules Third Quarter 2025 Earnings Call (Business Wire)
Oct-07-25 09:40AM	Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? (Zacks)
09:15AM	Black Diamond Therapeutics, Inc. (BDTX) Hit a 52 Week High, Can the Run Continue? (Zacks)
09:00AM	This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar (Zacks)
08:30AM	Loading…
08:30AM	Here's How Much a $1000 Investment in Exact Sciences Made 10 Years Ago Would Be Worth Today (Zacks)
06:59AM	New Study in Journal of the National Cancer Institute Finds Cologuard Plus Provides the Most Life-Years Gained with the Fewest Colonoscopies (Business Wire)
Oct-02-25 09:45AM	Here's Why Exact Sciences (EXAS) is a Strong Growth Stock (Zacks)
Oct-01-25 09:35AM	Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Sep-30-25 09:05AM	DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute (Zacks)
Sep-26-25 11:25AM	Guardants New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases. (Barrons.com)
Sep-25-25 02:24PM	Guardant's New Blood Test Can Detect Many Different Cancers. It's Promising the Same for Other Diseases. (Barrons.com)
12:40PM	Exact Sciences (EXAS) Stock Trades Up, Here Is Why (StockStory)
Sep-22-25 09:50AM	Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term (Zacks)
07:00AM	Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard Test (Business Wire)
03:18AM	Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives (Insider Monkey)
Sep-15-25 09:45AM	Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term (Zacks)
Sep-12-25 11:30AM	Why Is Kodiak Sciences (KOD) Down 1.2% Since Last Earnings Report? (Zacks)
08:51AM	Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs (Zacks)
08:50AM	Exact Sciences price target raised to $85 from $65 at Craig-Hallum (TipRanks)
05:33PM	Loading…
Sep-11-25 05:33PM	More Blood Tests for Cancer Hit the Market (Barrons.com)
Sep-10-25 10:04AM	Should You Continue to Hold EXAS Stock in Your Portfolio? (Zacks)
06:30AM	Exact Sciences Launches Cancerguard, First-of-Its-Kind Multi-Cancer Early Detection Blood Test (Business Wire)
Sep-04-25 04:13PM	Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run (Investor's Business Daily)
02:36PM	Why Exact Sciences (EXAS) Stock Is Trading Up Today (StockStory)
12:30PM	What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? (Zacks)
Sep-03-25 12:36PM	Exact Sciences (EXAS) Stock Trades Up, Here Is Why (StockStory)
Aug-31-25 12:10AM	Jefferies Reiterates a Buy Rating on Exact Sciences Corporation (EXAS) (Insider Monkey)
Aug-29-25 12:40AM	3 of Wall Street's Favorite Stocks We're Skeptical Of (StockStory)
Aug-27-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-19-25 06:00AM	Exact Sciences to Participate in September Investor Conferences (Business Wire)
Aug-15-25 09:15AM	TMO Receives FDA Approval for Oncomine Dx Target Test (Zacks)
12:02AM	2 Reasons to Sell EXAS and 1 Stock to Buy Instead (StockStory)
Aug-13-25 08:37AM	TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move? (Zacks) +7.59%
01:36AM	The Top 5 Analyst Questions From Exact Sciences's Q2 Earnings Call (StockStory)
Aug-12-25 10:30PM	[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:40PM	National Advertising Division Recommends Agendia Disclose Material Connection to Doctor Featured in Social Media Posts (GlobeNewswire)
08:27AM	EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up (Zacks)
03:06AM	EXAS Q2 Deep Dive: Portfolio Expansion and Productivity Drive Guidance Increase Amid Market Caution (StockStory)
Aug-11-25 11:07AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
09:45AM	Here's Why Exact Sciences (EXAS) is a Strong Growth Stock (Zacks)
09:06AM	Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 (GlobeNewswire)
Aug-08-25 10:36AM	IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates (Zacks) -5.03%
10:26AM	PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues (Zacks)
Aug-07-25 04:19PM	Is Exact Sciences, Down 8%, 'Throwing Good Money At Bad' In Its New Licensing Deal? (Investor's Business Daily) -7.99%
02:56PM	Exact Sciences Dip A Chance To Buy As Freenome Deal Fortifies Future: Analyst (Benzinga)
01:35PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
12:00PM	Exact Sciences (EXAS) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
11:20AM	MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
05:17AM	Exact Sciences to acquire US rights for Freenomes blood-based CRC test (Medical Device Network)
Aug-06-25 06:15PM	Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
05:27PM	Exact Sciences (NASDAQ:EXAS) Reports Strong Q2 But Stock Drops 15.2% (StockStory)
05:26PM	Exact Sciences Tumbles On Plans To License Blood-Based Colon Cancer Test (Investor's Business Daily)
05:09PM	Exact Sciences: Q2 Earnings Snapshot (Associated Press Finance)
04:12PM	How Exact Sciences Is Spending $775 Million To Dominate The Cancer-Screening Market (Investor's Business Daily)
04:06PM	Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome's Blood-Based Screening Test for Colorectal Cancer (PR Newswire)
04:05PM	Exact Sciences Announces Second Quarter 2025 Results (Business Wire)
04:05PM	Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests (Business Wire)
Aug-05-25 08:10AM	Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Astrin Biosciences Expands Leadership Team with Chief Marketing Officer Jaime LaMontagne to Support Next Phase of Growth (PR Newswire)
Aug-04-25 11:18PM	Exact Sciences (EXAS) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
02:07PM	Viatris Poised to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
08:30AM	Zimmer Biomet to Report Q2 Earnings: Here's What to Expect (Zacks)
08:10AM	TG Therapeutics (TGTX) Misses Q2 Earnings Estimates (Zacks)
Aug-01-25 11:23AM	Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
08:50AM	Will Healthcare Growth Help STE Beat on Q1 Earnings? (Zacks)
06:45AM	Exact Sciences expands partnership with Humana to improve colorectal cancer screening (Medical Device Network)
Jul-31-25 08:54AM	Will Exact Sciences Corporation (EXAS) Continue to Penetrate the Market with Its Cologuard Test? (Insider Monkey)
07:00AM	Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus Test (Business Wire)
Jul-30-25 11:07AM	Perrigo to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
10:00AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:20AM	Charles River Q2 Earnings Preview: What's in Store for the Stock? (Zacks)
Jul-29-25 01:43PM	Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report (PR Newswire)
09:14AM	Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards? (Zacks)
08:43AM	Tempus AI Taps Growing ICI Market With New xM Assay (Zacks)
08:26AM	Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock? (Zacks)
08:07AM	Henry Schein to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-28-25 11:40AM	KROS vs. EXAS: Which Stock Should Value Investors Buy Now? (Zacks)
10:36AM	CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-25-25 08:46AM	Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
08:38AM	HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now? (Zacks)
12:03AM	3 Reasons EXAS is Risky and 1 Stock to Buy Instead (StockStory)
Jul-24-25 12:10PM	Amarin Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
11:42AM	Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards? (Zacks)
09:45AM	Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:40AM	SubjectWell Appoints Veteran Healthcare Finance Leader Karl Stubelis as Chief Financial Officer (PR Newswire)
Jul-21-25 09:38AM	Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect (Zacks)
Jul-18-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Herriott James	SVP, General Counsel & Sec	Oct 09 '25	Sale	60.00	1,500	90,000	14,085	Oct 10 05:27 PM
Doyle James Edward	Director	Oct 09 '25	Sale	60.00	2,000	120,000	57,962	Oct 10 05:25 PM
Herriott James	Officer	Oct 09 '25	Proposed Sale	60.00	1,500	90,000		Oct 09 11:23 AM
Doyle James Edward	Director	Oct 09 '25	Proposed Sale	60.00	2,000	120,000		Oct 09 11:18 AM
Doyle James Edward	Director	Aug 13 '25	Sale	42.02	1,485	62,400	59,962	Aug 14 04:30 PM
Doyle James Edward	Director	Aug 13 '25	Proposed Sale	42.02	1,485	62,400		Aug 13 10:09 AM
ORVILLE JACOB A	EVP, GM, Screening	Aug 05 '25	Option Exercise	0.00	5,350	0	30,752	Aug 07 05:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '25	Option Exercise	0.00	5,350	0	27,943	Aug 07 05:30 PM
Sebelius Kathleen	Former Director	Jul 16 '25	Proposed Sale	53.11	8,164	433,605		Jul 16 04:22 PM
Zanotti Katherine S	Director	Jun 13 '25	Sale	53.20	3,207	170,612	72,759	Jun 16 05:30 PM
Zanotti Katherine S	Director	Jun 13 '25	Proposed Sale	53.20	3,207	170,612		Jun 13 09:50 AM
Bloomer Aaron	EVP, Chief Financial Officer	Apr 15 '25	Option Exercise	0.00	24,460	0	19,340	Apr 17 04:30 PM
Conroy Kevin T	President and CEO	Mar 07 '25	Option Exercise	22.38	66,723	1,493,261	1,203,269	Mar 10 05:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 28 '25	Option Exercise	0.00	4,265	0	16,339	Mar 04 04:48 PM
Conroy Kevin T	President and CEO	Feb 28 '25	Option Exercise	0.00	40,310	0	1,146,965	Mar 04 04:47 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 28 '25	Option Exercise	0.00	9,673	0	25,106	Mar 04 04:44 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 28 '25	Option Exercise	0.00	9,673	0	27,728	Mar 04 04:40 PM
Condella Sarah	EVP, Human Resources	Feb 28 '25	Option Exercise	0.00	7,738	0	84,399	Mar 04 04:37 PM
Condella Sarah	EVP, Human Resources	Feb 25 '25	Option Exercise	0.00	3,954	0	80,297	Feb 26 08:00 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 25 '25	Option Exercise	0.00	3,954	0	19,841	Feb 26 08:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 25 '25	Option Exercise	0.00	1,647	0	13,738	Feb 26 08:00 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 25 '25	Option Exercise	0.00	3,954	0	22,136	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 25 '25	Option Exercise	0.00	13,180	0	1,121,378	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 19 '25	Option Exercise	0.00	10,374	0	1,084,565	Feb 21 04:30 PM
COWARD D SCOTT	Director	Feb 19 '25	Option Exercise	0.00	2,248	0	52,831	Feb 21 04:30 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 19 '25	Option Exercise	0.00	2,248	0	16,688	Feb 21 04:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 19 '25	Option Exercise	0.00	1,729	0	14,487	Feb 21 04:30 PM
Condella Sarah	EVP, Human Resources	Feb 19 '25	Option Exercise	0.00	2,248	0	74,859	Feb 21 04:30 PM
Herriott James	SVP, General Counsel & Sec	Feb 19 '25	Option Exercise	0.00	865	0	10,731	Feb 21 04:30 PM
Conroy Kevin T	President and CEO	Nov 13 '24	Buy	51.35	19,500	1,001,325	1,074,191	Nov 13 12:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience